Opportunities and Challenges for Rescuing the Diabetic Microvasculature: Repurposing Anti-Inflammatory Drugs to Target the HO-1 Axis via Advanced Delivery Systems

Diabetic foot ulcers (DFUs) are characterized by severe microvascular impairment, where unresolved chronic inflammation and persistent oxidative stress disrupt endothelial function and arrest angiogenesis. The collapse of the vascular niche underscores the clinical need to shift the microenvironment from inflammation to active resolution. The heme oxygenase-1 (HO-1) signaling pathway is a critical endogenous defense mechanism that mitigates reactive oxygen species (ROS) and generates vasoprotective metabolites, making it an optimal target for vascular rescue. This review explores the potential strategic repurposing of classic anti-inflammatory agents, such as locally administered glucocorticoids, aspirin-triggered pro-resolving mediators, and macrolides such as azithromycin as upstream modulators of HO-1 to reprogram the hostile DFU microenvironment. While systemic administration of these drugs often delays wound healing and risks immunosuppression, their localized therapeutic potential is immense. Consequently, we highlight the pivotal role of advanced pharmaceutical engineering, specifically macrophage-targeted nanocarriers and stimuli-responsive hydrogels, designed to localize anti-inflammatory delivery directly within the ischemic tissue. By bridging immunopharmacology and advanced drug delivery, targeting the HO-1 axis provides a potential translational framework to modulate chronic inflammation and support microvascular regeneration, while acknowledging the current challenges for clinical implementation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-16
DOI
https://doi.org/10.3390/ph19111818
Primary Topic
Heme Oxygenase-1 and Carbon Monoxide
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Opportunities and Challenges for Rescuing the Diabetic Microvasculature: Repurposing Anti-Inflammatory Drugs to Target the HO-1 Axis via Advanced Delivery Systems

Emmanuel Moreau, Atziri Corin Chavez Alvarez
4 links
Pharmaceuticals
Heme Oxygenase-1 and Carbon Monoxide
article

Opportunities and Challenges for Rescuing the Diabetic Microvasculature: Repurposing Anti-Inflammatory Drugs to Target the HO-1 Axis via Advanced Delivery Systems

Emmanuel Moreau, Atziri Corin Chavez Alvarez
article en

Abstract

Diabetic foot ulcers (DFUs) are characterized by severe microvascular impairment, where unresolved chronic inflammation and persistent oxidative stress disrupt endothelial function and arrest angiogenesis. The collapse of the vascular niche underscores the clinical need to shift the microenvironment from inflammation to active resolution. The heme oxygenase-1 (HO-1) signaling pathway is a critical endogenous defense mechanism that mitigates reactive oxygen species (ROS) and generates vasoprotective metabolites, making it an optimal target for vascular rescue. This review explores the potential strategic repurposing of classic anti-inflammatory agents, such as locally administered glucocorticoids, aspirin-triggered pro-resolving mediators, and macrolides such as azithromycin as upstream modulators of HO-1 to reprogram the hostile DFU microenvironment. While systemic administration of these drugs often delays wound healing and risks immunosuppression, their localized therapeutic potential is immense. Consequently, we highlight the pivotal role of advanced pharmaceutical engineering, specifically macrophage-targeted nanocarriers and stimuli-responsive hydrogels, designed to localize anti-inflammatory delivery directly within the ischemic tissue. By bridging immunopharmacology and advanced drug delivery, targeting the HO-1 axis provides a potential translational framework to modulate chronic inflammation and support microvascular regeneration, while acknowledging the current challenges for clinical implementation.

PharmaceuticalsVol. 19(11)
Inserm (FR), Université Clermont Auvergne (FR), Imagerie Moléculaire et Stratégies Théranostiques (FR)
Good health and well-being
Heme Oxygenase-1 and Carbon Monoxide
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon